This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Acibadem Mehmet Ali Aydinlar Üniversitesi, Koç Üniversitesi, Sabanci Üniversitesi. Active years: 2024.
Company Filing History:
1 out of 1 
1 out of 34 
1 out of 40 
Years Active: 2024
Title: Burak Erman: Innovator in Cancer Research
Introduction
Burak Erman is a notable inventor based in Sariyer, Istanbul, Turkey. He has made significant contributions to the field of cancer research, particularly through his innovative work on DNA polymerase gamma inhibitors. His research focuses on developing compounds that selectively inhibit the growth of specific tumor cells.
Latest Patents
Burak Erman holds a patent for a "DNA polymerase gamma inhibitor and uses thereof." This patent describes Pol γ protein inhibitor compounds that are effective in selectively inhibiting the growth of MLH1 mutant or deficient tumor cells. The compounds interact directly with Pol γ, inhibiting its biological function, which leads to cancer cell death and reduced tumor growth in various assays. He has 1 patent to his name.
Career Highlights
Throughout his career, Burak has worked at prestigious institutions, including Acibadem Mehmet Ali Aydinlar University and Sabancı University. His work has been instrumental in advancing the understanding of cancer biology and developing targeted therapies.
Collaborations
Burak has collaborated with notable colleagues, including Meltem Muftuoglu and Batu Erman. These collaborations have further enriched his research and contributed to the scientific community's knowledge in the field.
Conclusion
Burak Erman is a dedicated inventor whose work in cancer research has the potential to make a significant impact on treatment options for patients. His innovative approach to targeting specific tumor cells showcases the importance of continued research in the fight against cancer.